project id: TCGA-UCEC; case submitter id: TCGA-AX-A1CA; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.9; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 70; days to birth: -25817; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1939; age at diagnosis: 25817; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 974.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 591; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-AX-A1CA-01A-12; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 10.0; percent tumor cells: 59.0; percent tumor nuclei: 60.0;